Core Insights - The 8th China International Import Expo (CIIE) is being held in Shanghai from November 5 to 10, showcasing 461 new products, technologies, and services across six major exhibition areas, emphasizing the importance of international trade cooperation and mutual benefits [1][2] - Amway China is leveraging the CIIE to highlight its commitment to health products and services, showcasing innovative solutions to meet the diverse health needs of the public [2][3] Group 1: CIIE Overview - The CIIE serves as a platform for global enterprises to tap into the Chinese market, promoting international economic cooperation and injecting positive energy into both the Chinese and global economies [1] - The event features new themes such as the silver economy, ice and snow economy, and sports economy, along with new consumption platforms focusing on digital and health consumption [1] Group 2: Amway's Commitment and Innovations - Amway China is focusing on health consumption, launching a new multi-vitamin and mineral powder product, "Little Gold Powder," which is the first "blue hat" multi-nutrient product in the Chinese market [3] - The company is showcasing a range of anti-aging products aimed at improving health expectancy, including solutions for cellular health, mobility, brain function, and skin health [3] Group 3: Research and Development - Amway has established a plant research center in Wuxi, integrating traditional Chinese medicine with modern biomedical approaches through its "Shennong" system, which includes extensive data on herbal remedies and health solutions [4] - The company is building a comprehensive local research and development system for traditional Chinese medicine, collaborating with various institutions to innovate and modernize agricultural practices [4] Group 4: Investment Plans - Amway has initiated a five-year investment plan of 2.1 billion RMB (approximately 0.3 billion USD) from 2023 to 2027, focusing on upgrading production facilities, enhancing digital infrastructure, and expanding experience centers [6] - The investment plan aims to strengthen Amway's supply chain and innovation capabilities in China, reinforcing its position as a strategic growth engine [6] Group 5: Strategic Alignment - Amway's strategies align with China's national goals of health and well-being, emphasizing digital infrastructure upgrades and a robust supply chain to support the health and wellness sector [7] - The company has successfully transitioned to a "second entrepreneurship" in China, with innovations and business models developed in China being adopted in other markets [7]

Core Insights - The China International Import Expo (CIIE) is increasingly recognized as a platform for promoting international trade cooperation and mutual benefits, contributing positively to both the Chinese and global economies [1] Company Highlights - Amway, celebrating 30 years in China, showcased its health products and services at the CIIE, addressing the diverse health needs of the public through innovative solutions and research achievements [2] - Amway's Chairman and President, Yu Fang, emphasized the expo's role in enhancing global companies' confidence in investing in China, positioning the country as a strategic market for Amway [4] - Amway launched a new product, a multi-vitamin and mineral powder called "Little Gold Powder," aimed at addressing nutritional imbalances in the Chinese diet, marking it as the first "blue hat" multi-nutrient powder in the market [5] Product Innovations - Amway presented a range of anti-aging products focused on improving healthspan, utilizing plant-based nutrients to enhance quality of life [7] - The company also highlighted products targeting metabolic health, dietary balance, and weight management, showcasing a comprehensive approach to health solutions [8] - Amway's Nutrilite brand is centered on plant nutrients, with significant investments in research and development, including a plant research center in Wuxi and the integration of AI technology for product development [8][10] Investment and Growth Strategy - Amway has initiated a five-year investment plan of 2.1 billion yuan (approximately 300 million USD) from 2023 to 2027, focusing on upgrading production facilities, digital infrastructure, and enhancing research capabilities [13] - The company aims to strengthen its supply chain and innovation capabilities in China, reinforcing its position as a strategic growth engine [14] - Amway's long-term commitment to the Chinese market is evident, with a focus on aligning its development with national strategies for health and well-being [12][14]